Development of core-shell scaffold with GelMA for cell encapsulation
There are around 20 million Type 1 diabetic patients worldwide and the only curative treatment involves islet transplantation. However, the shortage of donors and lifelong immunosuppression side effect drives the need for new regeneration treatment. Among all the approaches, cell encapsulation appea...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/74204 |